Individual differences in the in vitro response to cyclosporin A (CsA): possible heterogeneity in the involvement of the CD28-B7/BB1 pathway.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  The´rapie (Paris)

• Publication date

  1994-05-01

• Fields of study

  Medicine

• Identifiers
  PMID 7878594
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Differential immuno-suppressive effects of metabolic inhibitors on T-lymphocyte activation.

  1993cited by this paper
• B70 antigen is a second ligand for CTLA-4 and CD28

  1993cited by this paper
• The role of the CD28 receptor during T cell responses to antigen.

  1993cited by this paper
• Cloning of B7-2: a CTLA-4 counter-receptor that costimulates human T cell proliferation.

  1993cited by this paper
• FK506 and cyclosporin, molecular probes for studying intracellular signal transduction.

  1993cited by this paper
• Coexpression and functional cooperation of CTLA-4 and CD28 on activated T lymphocytes

  1992cited by this paper
• Cyclosporin A, FK-506, and rapamycin: pharmacologic probes of lymphocyte signal transduction.

  1992cited by this paper
• Immunosuppressants FK506 and rapamycin function as reversal agents of the multidrug resistance phenotype.

  1992cited by this paper
• FK-506- and CsA-sensitive activation of the interleukin-2 promoter by calcineurin

  1992cited by this paper
• Evidence for a functional receptor for cyclosporin A on the surface of lymphocytes.

  1992cited by this paper
• Identification of calcineurin as a key signalling enzyme in T-lymphocyte activation

  1992cited by this paper
• CTLA-4 is a second receptor for the B cell activation antigen B7

  1991cited by this paper
• THE EFFECT OF THE CD28 ACTIVATION PATHWAY ON THE IMMUNOSUPPRESSIVE ACTION OF CYCLOSPORINE

  1991cited by this paper
• Nuclear association of a T-cell transcription factor blocked by FK-506 and cyclosporin A

  1991cited by this paper
• Chemistry and biology of the immunophilins and their immunosuppressive ligands.

  1991cited by this paper
• Regulation of interleukin-2 gene enhancer activity by the T cell accessory molecule CD28.

  1991cited by this paper
• Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes.

  1991cited by this paper
• The synergy between naive and memory T cells during activation.

  1991cited by this paper
• Effect of cyclosporin A on the anti-CD3 antibody- and concanavalin A-induced activation and membrane potential of human T lymphocytes.

  1990cited by this paper
• Role of the CD28 receptor in T-cell activation.

  1990cited by this paper
• Differential sensitivity of human T helper cell pathways by in vitro exposure to cyclosporin A.

  1990cited by this paper
• Ciclosporin‐Induced Immunosuppression in Vitro

  1990cited by this paper
• Increased risk of rejection in renal transplant recipients with in vitro cyclosporin-resistant lymphoid responses.

  1989cited by this paper
• Cyclophilin and peptidyl-prolyl cis-trans isomerase are probably identical proteins

  1989cited by this paper
• Peptidyl-prolyl cis-trans isomerase is the cyclosporin A-binding protein cyclophilin

  1989cited by this paper
• The effects of immunosuppressive pharmacological agents on the induction of cytotoxic and suppressor T lymphocytes in vitro.

  1988cited by this paper
• Differential activation requirements for virgin and memory T cells.

  1988cited by this paper
• Cyclosporin A inhibits initiation but not progression of human T cell proliferation triggered by phorbol esters and calcium ionophores.

  1988cited by this paper
• Inhibition of in Vitro Alloreactivity by Cyclosporin A: Evidence for an Inter‐Individual Variation in Sensitivity

  1986cited by this paper
• Cyclosporin receptors on human lymphocytes.

  1982cited by this paper

• Lymphocyte-sensitivity to glucocorticoid correlates with the sensitivity to cyclosporin A and tacrolimus in chronic renal failure patients.

  1999cites this paper
• In vivo pharmacological effects of ciclosporin and some analogues.

  1996cites this paper
• Cyclophilin B mediates cyclosporin A incorporation in human blood T-lymphocytes through the specific binding of complexed drug to the cell surface.

  1996cites this paper